Oak Ridge Investments’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-80,205
Closed -$18.5M 158
2016
Q3
$18.5M Sell
80,205
-771
-1% -$188K 0.48% 67
2016
Q2
$18.7M Sell
80,976
-3,475
-4% -$801K 0.48% 64
2016
Q1
$22.6M Buy
84,451
+2,212
+3% +$633K 0.57% 56
2015
Q4
$25.7M Sell
82,239
-1,807
-2% -$538K 0.62% 50
2015
Q3
$22.8M Buy
84,046
+22,800
+37% +$7M 0.54% 57
2015
Q2
$18.6M Buy
61,246
+299
+0.5% +$89.2K 0.39% 71
2015
Q1
$18.1M Buy
+60,947
New +$17.4M 0.41% 73

Other funds holding AGN

Oak Ridge Investments's AGN Position: Q4 2016 in Review

Oak Ridge Investments sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 80,205 shares — an estimated $18.5M sold.

Oak Ridge Investments first reported a position in AGN in Q1 2015 and held it in 7 quarters. The position peaked at $25.7M in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Oak Ridge Investments reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Oak Ridge Investments sold 80,205 Allergan plc shares in Q4 2016, an estimated $18.5M.
  • Oak Ridge Investments first reported a position in Allergan plc in Q1 2015 and held it in 7 quarters.
  • Oak Ridge Investments's Allergan plc position peaked at $25.7M in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Oak Ridge Investments's 13F filing for Q4 2016, filed 13 Feb 2017.